StockTipsArenaBeta

BUY Aurobindo Pharma — Aastha Jain, Hem Securities

BUYAurobindo Pharma
Aurobindo Pharma share price target & all analyst calls

byAastha Jain, Hem SecuritiesHorizon: NA (inferred Swing (≤2wk))30 Oct 2026via Zee Business (Live)

Entry₹1,672.5Inferred
Target₹1,750
Total upside +4.63%
Stop loss₹1,600-4.33% risk
CMP₹1,681.46h ago
Active+0.53%+4.08%upside left 14d left
Follow Aastha Jain for new calls(34% target hit, 90 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 237 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 30 Oct, 10:20 pm IST
0 supporting2 neutral1 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (2)

Q2 FY27 results scheduled — board meets 04 Nov 2026

BSE · Board Meeting·In 4 days

(opens in new tab)

Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select players

NewsEt-Markets·19 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·30 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Aastha Jain, Hem Securities

Every call and its outcome